[Prognostic validity of biochemical data and immunofluorescence microscopy in acute hepatitis B (author's transl)].
For an early identification of chronic courses of hepatitis virus B infections a statistical prediction model based on simple biochemical parameters and immunofluorescence microscopy for the investigation of virus HBs and HBc antigen expression in liver tissue is established. As early as 3 weeks after maximum liver cell damage it is possible to identify chronic virus B infections and to predict the further course of hepatitis (CPH, CAH).
D000410:Alanine Transaminase / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood*; D001663:Bilirubin / Q000097:blood*; D005455:Fluorescent Antibody Technique; D006509:Hepatitis B / Q000175:diagnosis*; D006512:Hepatitis B Core Antigens / Q000032:analysis*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D011379:Prognosis
D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin
Die prognostische Wertigkeit klinisch-chemischer Daten und der Immunfluoreszensmikroskopie bei akuter Hepatitisvirus-B-Infektion.